College of


MSU researchers study compounds that could improve melanoma treatments

Through a grant funded by MSU Gran Fondo donations, researchers will study two compounds that could improve treatment for melanoma. The team believes a compound they developed and a second one already approved by the FDA could increase the number of melanoma patients who respond well to a therapeutic called immune checkpoint inhibitors and prevent them from developing resistance to the treatment. 

Dean's Update | September 10

"This is our second week of Women in Medicine Month, and, rather than writing about women in medicine myself, I am turning over the bulk of the update to College of Human Medicine women alumni writing brief pieces about women in medicine who inspired them. This week, Janet Osuch, MD (CHM ‘79, ’00), has written a lovely piece about fellow cancer surgeon Dr. Susan Love."

Read the latest Dean's Update.

COVID-19 Information and ResourcesReturn to WorkplaceTogether We WillOnline Store